the Potential Immunomodulatory Effects of Spirulina on Thalassemic Children

Tanta University

Status: Completed

Conditions: Beta Thalassemia Major

Treatments: Dietary Supplement: Spirulina

Study type: Interventional

Funder types: Other

Identifiers

NCT02674607

2132/10/13

Details and patient eligibility

About

The aim of this study is to evaluate the possible immunologic effects of spirulina in children with beta thalassemia.

Enrollment: 60 patients

Sex: All

Ages: 4 to 18 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• children with thalassemia major

Exclusion criteria

• children with other chronic hemolytic anemias

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

60 participants in 2 patient groups

patients

Experimental group

Description:

thirty children with beta thalassemia major will receive oral spirulina (tablets=500 mg) for 3 months with a dose of 250 mg/kg/day (maximum dose 4 gm)

Treatment:

Dietary Supplement: Spirulina

controls

No Intervention group

Description:

thirty healthy children of matched age and sex